Arcturus Therapeutics Appoints Four New Directors and Reaches Settlement Agreement with Founder Joseph E. Payne - CNBC.com -BoardProspects

Arcturus Therapeutics Appoints Four New Directors and Reaches Settlement Agreement with Founder Joseph E. Payne

CNBC.com May 29 2018 BoardMoves

SAN DIEGO, May 29, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ:ARCT) (“Arcturus” or the “Company), a leading RNA medicines company, today announced that, as part of a settlement agreement, it has appointed four new independent directors, Dr. Peter Farrell, Mr. Andrew Sassine, Mr. James Barlow and Dr. Magda Marquet, to its Board, effective as of May 27, 2018...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- PepsiCo Puts Trian Business Advisor On Board also categorized in BoardMoves
- Michael Cola Joins the Board of Vanda Pharmaceuticals also mentions Board of Trustees
- Carl Icahn: Netflix Poison-Pill Move 'Reprehensible' also published in CNBC.com
- Cloud Foundry Board Elects EMC CTO As Chair also categorized in BoardMoves
- The CIO-Plus Of Vivint Smart Home Named To The Board Of Domo also categorized in BoardMoves
- Duke CEO: Board Lost Confidence in Progress Chief also published in CNBC.com
- Marissa Mayer's Huge Payday also published in CNBC.com
- Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board also categorized in BoardMoves
- Pandora Jewelry Names New CEO and Board Chairman also categorized in BoardMoves
- Honest Company Diversifies Its Leadership With A Second Female Board Member also categorized in BoardMoves

Search:
Categories
1. BoardProspects Features:
  BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content
Quotes
1. We are pleased to have come together to reach this very positive outcome that allows Arcturus to move forward, focused on creating substantial value for all shareholders.
Topics Mentioned
- Board of directors
- technology
- Nasdaq
- NYSE
- SEC
- Bank
- acquisition
- Europe
- Corporate Governance
- Japan
- Harvard
- MBA
- Board of Trustees
- Pfizer
- Johnson & Johnson
- Allergan
- Takeda
- Scripps
- Arcturus Therapeutics
- CEO
- Leadership
- Pharmaceutical Companies
- Communication